Cookie Img
Send SMS    Call Me Free
Home » Products » Anti-Cancer Products » Bortezomib

Bortezomib

Bortezomib
Bortezomib
Product Code : #098
Brand Name : Bortenat
Product Specifications
  • Formulations Type
  • Injectables
  • Formulations Form
  • Liquid
  • Gender/Age Group
  • Adult
Trade Information
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • Main Domestic Market
  • All India
Product Description
Bortezomib (BAN, INN and USAN; marketed as Velcade by Millennium Pharmaceuticals; Neomib by Getwell and Bortecad by Cadila Healthcare) is an anti-cancer drug and the first therapeutic proteasome inhibitor to be used in humans. Proteasomes are cellular complexes that break down proteins. In some cancers, the proteins that normally kill cancer cells are broken down too quickly. Bortezomib interrupts this process and lets those proteins kill the cancer cells. It is approved in the U.S. and Europe for treating relapsed multiple myeloma and mantle cell lymphoma.[1][2][3] In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.

AMBICA PHARMA

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



AMBICA PHARMA All Rights Reserved.